FDA issued a Warning Letter to Anicare Pharmaceuticals Pvt Ltd. on 2/28/2019 as a result of this inspection.
483 Anicare Pharmaceuticals Aug 2018
483 Anicare Pharmaceuticals Aug 2018
Liming Zhang FDA$119.00 - Available NowFDA investigators audited the Anicare Pharmaceuticals - Navi Mumbai, India facility and issued inspectional observations (via FDA 483) on 03 Aug 2018.
Product details
- Category: Human Drugs
- Inspection end: 03 Aug 2018
- Location: Navi Mumbai, India
- FEI: 3007450508
